Health Care & Life Sciences » Biotechnology | Nymox Pharmaceutical Corp.

Nymox Pharmaceutical Corp.

Nymox Pharmaceutical Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
60.74 M
Public Float
31.09 M
Nymox Pharmaceutical Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.17
Market Cap
$97.45 M
Shares Outstanding
67.68 M
Public Float
37.98 M

Profile

Address
Bay & Deveaux Streets
Nassau NW
Bahamas
Employees -
Website http://www.nymox.com
Updated 07/08/2019
Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe.

Financials

View All

Paul Averback
Chairman, President & Chief Executive Officer
Randall Lanham
Secretary, Director & General Counsel